143.91

3.05% -4.53

After Hours: 143.91

Iqvia Holdings Inc (IQV)

Overview News Price History Option Chain Financials Discussions Forecast

Iqvia Holdings Inc stock is traded at $143.91, with a volume of 3.30M. It is down -3.05% in the last 24 hours and down -22.17% over the past month. IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

Previous Close:

$148.44

Open:

$149.325

24h Volume:

3.30M

Relative Volume:

1.98

Market Cap:

$26.61B

Revenue:

$15.41B

Net Income/Loss:

$1.37B

P/E Ratio:

19.19

EPS:

7.5

Net Cash Flow:

$2.11B

1W Performance:

+0.48%

1M Performance:

-22.17%

6M Performance:

-38.47%

1Y Performance:

-36.67%

1-Day Range:

$143.50

$149.32

1-Week Range:

$140.64

$152.48

52-Week Range:

$135.97

$252.88

Iqvia Holdings Inc Stock (IQV) Company Profile

Name

Iqvia Holdings Inc

Sector

Healthcare (1151)

Industry

Diagnostics & Research (58)

Phone

919-998-2000

Address

2400 ELLIS ROAD, DURHAM, NC

Employee

88,000

Twitter

@IQVIA_global

Next Earnings Date

2024-10-31

Latest SEC Filings

IQV's Discussions on Twitter

Compare IQV with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IQV Iqvia Holdings Inc	143.91	26.61B	15.41B	1.37B	2.11B	7.50
TMO Thermo Fisher Scientific Inc	427.50	169.62B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	186.83	138.06B	23.88B	3.90B	5.30B	5.28
IDXX Idexx Laboratories Inc	411.49	32.79B	3.90B	887.87M	798.08M	10.67
A Agilent Technologies Inc	102.48	29.99B	6.53B	1.26B	1.31B	4.35

Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Downgrade	Barclays	Overweight → Equal Weight
Feb-03-25	Downgrade	BTIG Research	Buy → Neutral
Dec-20-24	Initiated	Stephens	Overweight
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-04-24	Initiated	RBC Capital Mkts	Outperform
Jul-24-24	Downgrade	Jefferies	Buy → Hold
Jun-06-24	Initiated	Goldman	Buy
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Feb-13-24	Initiated	BTIG Research	Buy
Nov-02-23	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-06-23	Initiated	HSBC Securities	Buy
Mar-17-23	Initiated	Truist	Buy
Dec-06-22	Initiated	Cowen	Outperform
Nov-17-22	Downgrade	Citigroup	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Jul-15-22	Initiated	SVB Leerink	Outperform
May-24-22	Initiated	Guggenheim	Buy
Apr-29-22	Upgrade	Piper Sandler	Neutral → Overweight
Apr-25-22	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-05-21	Resumed	Credit Suisse	Outperform
Apr-16-21	Upgrade	Stephens	Equal-Weight → Overweight
Mar-08-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-03-21	Initiated	Barclays	Overweight
Jul-07-20	Initiated	Stephens	Equal-Weight
Mar-02-20	Initiated	Deutsche Bank	Buy
Jan-08-20	Initiated	Wells Fargo	Overweight
Jan-07-20	Initiated	Citigroup	Buy
Dec-13-19	Upgrade	CFRA	Sell → Hold
Nov-14-19	Upgrade	Wolfe Research	Peer Perform → Outperform
Jun-21-19	Upgrade	Mizuho	Neutral → Buy
May-28-19	Initiated	SVB Leerink	Outperform
Jan-18-19	Upgrade	Jefferies	Hold → Buy
Oct-09-18	Initiated	UBS	Buy
Oct-02-18	Reiterated	Robert W. Baird	Outperform
Jul-25-18	Upgrade	BofA/Merrill	Neutral → Buy
Jul-25-18	Reiterated	Stifel	Buy
Jul-03-18	Upgrade	Raymond James	Outperform → Strong Buy
Apr-13-18	Upgrade	Goldman	Neutral → Buy
Mar-07-18	Upgrade	SunTrust	Hold → Buy
Jan-19-18	Initiated	Evercore ISI	Outperform

View All

Iqvia Holdings Inc Stock (IQV) Latest News

Apr 17, 2025

(IQV) On The My Stocks Page - news.stocktradersdaily.com

Apr 17, 2025

Apr 15, 2025

Record-Breaking $102B Biopharma R&D Investment Signals Industry Recovery - Stock Titan

Apr 15, 2025

Apr 14, 2025

Bank of America Adjusts Price Target for Iqvia (IQV) to $190 | I - GuruFocus

Apr 14, 2025

Apr 11, 2025

Barclays Downgrades Iqvia (IQV) Amid Concerns Over Pharma Tariffs | IQV Stock News - GuruFocus

Apr 11, 2025

Truist cuts IQVIA stock price target to $216, keeps Buy rating - Investing.com Canada

Apr 11, 2025

Apr 10, 2025

IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? - Yahoo Finance

Apr 10, 2025

IQVIA (IQV) Downgraded by Barclays Over Tariff Concerns - GuruFocus

Apr 10, 2025

Truist Adjusts IQVIA Holdings' PT to $216 From $263, Keeps Buy Rating - marketscreener.com

Apr 10, 2025

Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - Seeking Alpha

Apr 10, 2025

Truist Lowers Iqvia (IQV) Price Target Amid CRO Sector Challenges | IQV Stock News - GuruFocus

Apr 10, 2025

Barclays Downgrades IQVIA Holdings to Equalweight From Overweight, Adjusts PT to $170 From $235 - MarketScreener

Apr 10, 2025

Barclays cuts IQVIA stock rating, slashes price target to $170 By Investing.com - Investing.com South Africa

Apr 10, 2025

Barclays cuts IQVIA stock rating, slashes price target to $170 - Investing.com Australia

Apr 10, 2025

Apr 09, 2025

Evercore ISI Adjusts Price Target on IQVIA Holdings to $165 From $245, Maintains Outperform Rating - MarketScreener

Apr 09, 2025

Apr 08, 2025

Goldman Sachs Adjusts IQVIA Holdings Price Target to $200 From $230, Maintains Buy Rating - MarketScreener

Apr 08, 2025